Gencosmanoglu Rasim, Aker Fugen, Kir Gozde, Tozun Nurdan
Department of General Surgery, Marmara University School of Medicine, Istanbul, Turkey.
World J Surg Oncol. 2006 Jul 6;4:42. doi: 10.1186/1477-7819-4-42.
Isolated splenic metastases from colorectal cancer are very rare and there are only 13 cases reported in the English literature so far. Most cases are asymptomatic and the diagnosis is usually made by imaging studies during the evaluation of rising CEA level postoperatively.
A 76-year-old man underwent an extended left hemicolectomy for synchronous colon cancers located at the left flexure and the sigmoid colon. The tumors were staged as IIIC (T3N2M0) clinically and the patient received adjuvant chemotherapy. During the first year follow-up period, the patient remained asymptomatic with normal levels of laboratory tests including CEA measurement. However, a gradually rising CEA level after the 14th postoperative month necessitated further imaging studies including computed tomography of the abdomen which revealed a mass in the spleen that was subsequently confirmed by 18FDG- PET scanning to be an isolated metastasis. The patient underwent splenectomy 17 months after his previous cancer surgery. Histological diagnosis confirmed a metastatic adenocarcinoma with no capsule invasion. After an uneventful postoperative period, the patient has been symptom-free during the one-year of follow-up with normal blood CEA levels, although he did not accept to receive any further adjuvant therapy. To the best of our knowledge, this 14th case of isolated splenic metastasis from colorectal carcinoma is also the first reported case of splenic metastasis demonstrated preoperatively by 18FDG PET-CT fusion scanning which revealed its solitary nature as well.
Isolated splenic metastasis is a rare finding in the follow-up of colorectal cancer patients and long-term survival can be achieved with splenectomy.
结直肠癌孤立性脾转移非常罕见,迄今为止英文文献中仅报道了13例。大多数病例无症状,诊断通常是在术后癌胚抗原(CEA)水平升高评估期间通过影像学检查做出的。
一名76岁男性因位于左结肠曲和乙状结肠的同步性结肠癌接受了扩大左半结肠切除术。肿瘤临床分期为IIIC期(T3N2M0),患者接受了辅助化疗。在第一年的随访期间,患者无症状,包括CEA检测在内的实验室检查结果正常。然而,术后第14个月后CEA水平逐渐升高,需要进一步进行影像学检查,包括腹部计算机断层扫描,结果显示脾脏有一个肿块,随后经18氟脱氧葡萄糖正电子发射断层扫描(18FDG - PET)证实为孤立性转移瘤。该患者在先前癌症手术后17个月接受了脾切除术。组织学诊断证实为转移性腺癌,无包膜侵犯。术后恢复顺利,尽管患者未接受任何进一步的辅助治疗,但在随访的一年中一直无症状,血液CEA水平正常。据我们所知,这是第14例结直肠癌孤立性脾转移病例,也是首例术前通过18FDG PET - CT融合扫描证实的脾转移病例,该扫描也显示了其孤立性。
孤立性脾转移在结直肠癌患者随访中是一种罕见的发现,脾切除可实现长期生存。